Navigation Links
Medicare Approves in Home Sleep Apnea Testing
Date:4/8/2008

Insurance Companies Expected To Match Medicare Policy

SAN CARLOS, Calif., April 8, 2008 /PRNewswire/ -- The Centers for Medicare and Medicaid Services (CMS) have approved at-home sleep testing for obstructive sleep apnea (OSA). Previous policy had mandated that suspected sleep apnea sufferers undergo facility-based polysomnography. The new policy allows continuous positive airway pressure (CPAP) treatment for Medicare patients who are diagnosed via unattended home monitoring devices. This decision will likely prompt increased coverage from insurance companies around the country.

"SleepQuest is very excited about the change in coverage as it demonstrates that our portable sleep testing program, which we have successfully offered for the past 14 years, is a viable and effective alternative to sleep lab testing," said Robert Koenigsberg, SleepQuest President. "Dr. William Dement, SleepQuest's Chief Scientific Advisor and I applaud CMS's in-depth analysis of this topic, providing greater access and allowing the many sufferers of OSA to benefit from treatment."

While coverage has been approved, providers of in-home sleep testing are still waiting to hear the specific date that the policy will actually go into effect. However, several insurance providers have already begun to align their coverage with Medicare.

"We were quite happy to learn that upon hearing of the approval, Aetna immediately revised their medical policy to mirror Medicare's," said Lori Schulman, SleepQuest's Director of Contracting. "We expect other plans that follow Medicare, such as Triwest, will also adopt this policy. SleepQuest has also been in contact with insurance providers, such as Blue Cross of California, who currently allow home sleep testing but impose coverage restrictions."

SleepQuest will continue to work closely with Medicare and insurance companies to ensure that coverage expands, making treatment more available and affordable to more patients. An estimated 30 million Americans suffer from some form of sleep apnea.

SleepQuest has been a leader in at-home testing and treatment of sleep apnea for more than 14 years. With Medicare's official approval, they anticipate significant growth and expansion. A new San Francisco office is scheduled to open by July.

"We anticipate that as coverage continues expanding, we will be able to focus on getting more patients tested quickly and comfortably in the home environment," said Koenigsberg. "We look forward to helping even more OSA sufferers with our comprehensive approach to wellness and vitality."


'/>"/>
SOURCE SleepQuest
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. STAAR Surgicals Collamer(R) IOL Designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services
2. MedicareCRM(TM) to Speak at IIR Medicare Advantage Congress
3. Medicare Coverage Recommended for In-Home Sleep Testing
4. House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels
5. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. 3SBio Inc. Approves Share Repurchase Program
8. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
9. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
10. FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
11. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... 27, 2017 , ... Oncolinx, a spin-out of the Center ... truly taken their cancer research out of this world. On April 22, 2017, ... to the International Space Station’s (ISS) U.S. National Laboratory, managed by the Center ...
(Date:4/27/2017)... Luxembourg (PRWEB) , ... April 27, 2017 , ... Mitotech ... study in Leber’s Hereditary Optic Neuropathy (LHON) patients. LHON is a rare devastating genetic ... efficacy of SkQ1 eye drops in a group of 20 patients carrying 11778, 14484 ...
(Date:4/27/2017)... ... 2017 , ... Arrowhead Publishers is pleased to announce the ... San Diego, CA on September 27-28, 2017. Leaders from the pharmaceutical, biotech, device ... the treatment of various types of pain. There are also extended networking opportunities, ...
(Date:4/27/2017)... ... April 27, 2017 , ... Sierra Instruments announces ... capillary thermal mass flow technology provide exponentially more accurate mass flow data than ... of all industrial processes—such as those involving chemical reactions, combustion, respiration, pharmaceutical, and ...
Breaking Biology Technology:
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/23/2017)... Research and Markets has announced the addition ... - Industry Forecast to 2025" report to their offering. ... The Global Vehicle ... around 8.8% over the next decade to reach approximately $14.21 billion ... estimates and forecasts for all the given segments on global as ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
Breaking Biology News(10 mins):